Ensuring a robust and safe supply chain for pharmaceuticals in Europe
Until March 2020 and the emergence of the COVID-19 pandemic in Europe, the concepts of ‘sovereignty’ and ‘strategic autonomy’, used
Read moreUntil March 2020 and the emergence of the COVID-19 pandemic in Europe, the concepts of ‘sovereignty’ and ‘strategic autonomy’, used
Read moreWhen planning strategic autonomy in health, policymakers face a problem known in behavioural science as hyperbolic discounting. This means that
Read moreEurope is home to a rich innovation ecosystem with start-ups, world-class research institutions, top universities for life sciences and many
Read moreA strong Union needs a strong industrial sector to promote competitiveness, create jobs and guarantee a high quality of life.
Read moreAs the COVID-19 pandemic unfolded, the European Union (EU), its Member States and institutions swiftly managed to work together and
Read moreAs I started to write this article, the COP26 climate conference was just beginning. Twitter was abuzz with people tweeting
Read moreAs the place where most people live, and where most emissions are produced, the engagement of urban municipalities is paramount
Read moreOver the past decade, the number of cancer survivors has increased substantially, and with an ageing European population and increasingly
Read more